Announce topline data for Phase 2a POC trial and combination MAD trials
Delivered after the deadline (41 days after the deadline)
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Mar 2025
- Due
- 30 Jun 2026
- Delivered
- 10 Aug 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“with topline data for both anticipated in mid-2026”
What we found
Evidence strength A What the grades mean
Sionna announced topline data for both the SION-719 Phase 2a trial and the SION-451 Phase 1 combination trial on August 10, 2026, after the mid-2026 (June 30) deadline.
-
A Sionna Therapeutics Reports Second Quarter 2026 Financial Results
“Topline data from this trial are on track for this summer.” ✓ confirmed on the page
-
A Press Release of Sionna Therapeutics, Inc. dated
“Topline data from this trial are anticipated in mid-2026.” ✓ confirmed on the page
-
B Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
“today reported topline data from two nucleotide binding domain 1 stabilizer programs”
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Announce
- Deliverable
- Topline data for Phase 2a and combination MAD trials
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Sionna Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-SION-001951 · Corrections policy